Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

New treatments for androgenetic alopecia show promise but need more research for validation.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

The document discussed hair loss causes and treatments but didn't give a final summary.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.